Warrington, PA, United States of America

Yong Gong

USPTO Granted Patents = 18 (Patent Applications = 4)

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 85(Granted Patents)

Company Filing History:

18 out of 2,076

Janssen Pharmaceutica Nv

patents

3 out of 170

Ortho-clinical Diagnostics, Inc

patents

where one patent can have more than one assignee

Years Active: 2014-2022

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11226345 - Antibodies to olanzapine haptens and use thereof (2022-01-18),

2. 11214566 - Substituted pyridine derivatives useful as C-FMS kinase inhibitors (2022-01-04),

3. 11104742 - Antibodies to quetiapine and use thereof (2021-08-31),

4. 11046786 - Antibodies to olanzapine and use thereof (2021-06-29),

5. 10800764 - Substituted pyridine derivatives useful as C-FMS kinase inhibitors (2020-10-13),

6. 10712353 - Antibodies to olanzapine haptens and use thereof (2020-07-14),

7. 10465013 - Antibodies to quetiapine haptens and use thereof (2019-11-05),

8. 10435478 - Antibodies to quetiapine and use thereof (2019-10-08),

9. 10344098 - Antibodies to olanzapine and use thereof (2019-07-09),

10. 10288631 - Antibodies to quetiapine and use thereof (2019-05-14),

11. 10071991 - Substituted pyridine derivatives useful as c-fms kinase inhibitors (2018-09-11),

12. 9850318 - Antibodies to quetiapine haptens and use thereof (2017-12-26),

13. 9611259 - Substituted pyridine derivatives useful as C-FMS kinase inhibitors (2017-04-04),

14. 9494608 - Antibodies to olanzapine and use thereof (2016-11-15),

15. 9410972 - Antibodies to quetiapine and use thereof (2016-08-09),

Title: Yong Gong: Innovator in Pharmaceutical Research

Introduction

Yong Gong, located in Warrington, PA, is a prolific inventor with a remarkable portfolio of 18 patents. His work mainly revolves around pharmaceuticals and biotechnology, contributing significantly to medical advancements and drug detection technologies.

Latest Patents

Gong's recent innovations include a patent for antibodies to olanzapine haptens. This antibody is important for detecting olanzapine in various samples using a competitive immunoassay method. Notably, it can be integrated into a lateral flow assay device, allowing for point-of-care detection of olanzapine and multiplex detection alongside other medications such as aripiprazole, quetiapine, and risperidone. Another significant patent features substituted pyridine derivatives, which serve as c-fms kinase inhibitors. This patent also outlines pharmaceutical compositions containing these derivatives, highlighting their potential in treating disorders mediated by c-fms kinase.

Career Highlights

Yong Gong has collaborated with leading companies in the pharmaceutical sector, including Janssen Pharmaceutica NV and Ortho Clinical Diagnostics, Inc. His experience in these organizations has been instrumental in the development and commercialization of innovative therapeutic solutions.

Collaborations

Throughout his career, Gong has worked alongside notable colleagues, including Rhys Salter and Matthew Garrett Donahue. These collaborative efforts have fostered an environment of creativity and innovation, driving advancements in the medical field.

Conclusion

Yong Gong's contributions to pharmaceutical research and his impressive portfolio of patents underscore his commitment to advancing healthcare solutions. Through his innovative spirit and collaborative efforts, he continues to make significant strides in the detection and treatment of medical conditions.

This text is generated by artificial intelligence and may not be accurate.